Adlai Nortye Ltd ADR (ANL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANL | PBYI | EPRX | ||
| Company | Adlai Nortye Ltd ADR | Puma Biotechnology | Eupraxia Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.47 | 8.39 | 6.53 | ||
| High | 10.47 | 8.48 | 6.53 | ||
| Low | 10.22 | 8.37 | 6.18 | ||
| Latest | 10.49 | 8.64 | 6.43 | ||
| Change | -0.14 | +0.23 | -0.09 | ||
| % Change | -1.32% | +2.73% | -1.38% | ||
| Volume | 2,211 | 13,807 | 8,696 | ||
| 20-Day Average Volume | 189,287 | 390,618 | 392,478 | ||
| Previous Close | 10.63 | 8.41 | 6.52 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 10.38 | 8.01 | 6.55 | ||
| 20-Day Raw Stochastic | 60.40% | 93.06% | 42.68% | ||
| 20-Day Relative Strength | 49.52 | 62.54 | 46.03 | ||
| Weighted Alpha | +23.09 | +95.75 | +8.70 | ||
| Today's Opinion | 24% Buy | 100% Buy | 88% Sell | ||
| Previous Opinion | 24% Buy | 100% Buy | 88% Sell | ||
| Last Month's Opinion | 56% Buy | 56% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.47% since 07/09/26 | +6.84% since 07/09/26 | -7.74% since 07/09/26 | ||
| Low | 8.88 on 07/14/26 | 7.70 on 07/10/26 | 6.19 on 07/15/26 | ||
| High | 10.70 on 07/15/26 | 8.54 on 07/15/26 | 7.03 on 07/10/26 | ||
| 1-Month | |||||
| %Chg | +5.77% since 06/16/26 | +17.71% since 06/16/26 | +5.72% since 06/16/26 | ||
| Low | 8.54 on 07/02/26 | 7.10 on 06/17/26 | 5.83 on 06/24/26 | ||
| High | 12.00 on 06/30/26 | 8.54 on 07/15/26 | 7.11 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | -22.35% since 04/16/26 | +16.57% since 04/16/26 | -11.46% since 04/16/26 | ||
| Low | 8.54 on 07/02/26 | 6.60 on 05/19/26 | 5.63 on 06/16/26 | ||
| High | 17.25 on 04/21/26 | 8.54 on 07/15/26 | 8.13 on 05/01/26 | ||
| 6-Month | |||||
| %Chg | +490.56% since 01/16/26 | +32.50% since 01/16/26 | -27.14% since 01/16/26 | ||
| Low | 1.63 on 01/20/26 | 5.50 on 03/02/26 | 5.63 on 06/16/26 | ||
| High | 17.25 on 04/21/26 | 8.54 on 07/15/26 | 9.32 on 01/21/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 425,200 | 428,061 | 423,924 | ||
| Shares Outstanding, K | 40,000 | 50,899 | 65,019 | ||
| Annual Sales | 5,000,000 | 228,370,000 | 0 | ||
| Annual Net Income | -35,530,000 | 31,110,000 | -38,580,000 | ||
| Last Quarter Sales | 0 | 44,810,000 | 0 | ||
| Last Quarter Net Income | -63,397,000 | -3,750,000 | -12,650,000 | ||
| 60-Month Beta | 1.05 | 1.20 | 1.05 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 09/29/23 | -0.04 on 05/07/26 | -0.23 on 05/12/26 | ||
| Earnings Date | 04/29/26 | 08/06/26 | 08/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.25 | 0.00 | ||